Rockwell Medical expands global distribution in Dominican Republic and Bermuda

Rockwell Medical entered into a new and expanded distribution agreement with BioNuclear and Atlantic Medical International or AMI, respectively. In the aggregate, these agreements are expected to generate approximately $1M in annual revenues for the company. BioNuclear specializes in the marketing of reagents, equipment and furniture for clinical laboratories, medical equipment and devices, vaccines for human consumption and supplies for hemodialysis and peritoneal dialysis. Rockwell Medical signed a five-year distributor agreement with BioNuclear through which BioNuclear may import, sell, promote and distribute Rockwell Medical’s hemodialysis concentrates products within the Dominican Republic. The agreement will remain in effect for five years and BioNuclear has the option to extend the agreement for an additional five years beyond the original term. AMI is a supplier of medical products and equipment for the acute and continuing care markets in Bermuda. AMI has been a distributor of Rockwell Medical products since 2022. The amended distribution agreement between Rockwell Medical and AMI expands the list of hemodialysis products that AMI is purchasing from the company, includes purchasing commitments, and generates a profit margin consistent with Rockwell Medical’s gross margin guidance for 2024.